| Year |
Citation |
Score |
| 2020 |
Sharp ME, Duncan K, Foerde K, Shohamy D. Dopamine is associated with prioritization of reward-associated memories in Parkinson's disease. Brain : a Journal of Neurology. 143: 2519-2531. PMID 32844197 DOI: 10.1093/Brain/Awaa182 |
0.411 |
|
| 2019 |
Cassidy CM, Zucca FA, Girgis RR, Baker SC, Weinstein JJ, Sharp ME, Bellei C, Valmadre A, Vanegas N, Kegeles LS, Brucato G, Jung Kang U, Sulzer D, Zecca L, Abi-Dargham A, et al. Neuromelanin-sensitive MRI as a noninvasive proxy measure of dopamine function in the human brain. Proceedings of the National Academy of Sciences of the United States of America. PMID 30796187 DOI: 10.1073/Pnas.1807983116 |
0.354 |
|
| 2013 |
Sharp ME, Viswanathan J, McKeown MJ, Appel-Cresswell S, Stoessl AJ, Barton JJ. Decisions under risk in Parkinson's disease: preserved evaluation of probability and magnitude. Neuropsychologia. 51: 2679-89. PMID 23954375 DOI: 10.1016/J.Neuropsychologia.2013.08.008 |
0.424 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2015 |
Sharp ME, Foerde K, Daw ND, Shohamy D. Dopamine selectively remediates 'model-based' reward learning: a computational approach. Brain : a Journal of Neurology. PMID 26685155 DOI: 10.1093/Brain/Awv347 |
0.286 |
|
| 2022 |
Lahlou S, Gabitov E, Owen L, Shohamy D, Sharp M. Preserved motor memory in Parkinson's disease. Neuropsychologia. 167: 108161. PMID 35041839 DOI: 10.1016/j.neuropsychologia.2022.108161 |
0.285 |
|
| 2012 |
Sharp ME, Viswanathan J, Lanyon LJ, Barton JJ. Sensitivity and bias in decision-making under risk: evaluating the perception of reward, its probability and value. Plos One. 7: e33460. PMID 22493669 DOI: 10.1371/Journal.Pone.0033460 |
0.278 |
|
| 2019 |
Gan-Or Z, Rao T, Leveille E, Degroot C, Chouinard S, Cicchetti F, Dagher A, Das S, Desautels A, Drouin-Ouellet J, Durcan T, Gagnon JF, Genge A, Karamchandani J, Lafontaine AL, ... ... Sharp M, et al. The Quebec Parkinson Network: A Researcher-Patient Matching Platform and Multimodal Biorepository. Journal of Parkinson's Disease. PMID 31868683 DOI: 10.3233/Jpd-191775 |
0.255 |
|
| 2015 |
Sharp ME, Caccappolo E, Mejia-Santana H, Tang MX, Rosado L, Orbe Reilly M, Ruiz D, Louis ED, Comella C, Nance M, Bressman S, Scott WK, Tanner C, Waters C, Fahn S, et al. The relationship between obsessive-compulsive symptoms and PARKIN genotype: The CORE-PD study. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 278-83. PMID 25393808 DOI: 10.1002/Mds.26065 |
0.203 |
|
| 2014 |
Sharp ME, Marder KS, Côté L, Clark LN, Nichols WC, Vonsattel JP, Alcalay RN. Parkinson's disease with Lewy bodies associated with a heterozygous PARKIN dosage mutation. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 566-8. PMID 24375549 DOI: 10.1002/Mds.25792 |
0.199 |
|
| 2009 |
Phillips P, Chapman K, Sharp M, Harrison P, Vortel J, Steiner T, Bowie W. Dexamethasone in Cryptococcus gattii central nervous system infection. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 49: 591-5. PMID 19589083 DOI: 10.1086/603554 |
0.147 |
|
| 2021 |
da Silva Castanheira K, Sharp M, Otto AR. The impact of pandemic-related worry on cognitive functioning and risk-taking. Plos One. 16: e0260061. PMID 34793534 DOI: 10.1371/journal.pone.0260061 |
0.119 |
|
| 2021 |
Pilgrim MJD, Ou ZA, Sharp M. Exploring reward-related attention selectivity deficits in Parkinson's disease. Scientific Reports. 11: 18751. PMID 34548517 DOI: 10.1038/s41598-021-97526-7 |
0.119 |
|
| 2012 |
Sharp M, Javidan M. Immunomodulation in adult epilepsy: the role of IVIG. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 39: 584-91. PMID 22931698 DOI: 10.1017/s0317167100015304 |
0.119 |
|
| 2013 |
Sharp ME, Laule C, Nantel S, Mädler B, Aul RB, Yip S, Sirrs S. Stem cell transplantation for adult-onset krabbe disease: report of a case. Jimd Reports. 10: 57-9. PMID 23430802 DOI: 10.1007/8904_2012_203 |
0.1 |
|
| 2022 |
Bogdanov M, LoParco S, Ross Otto A, Sharp M. Dopaminergic medication increases motivation to exert cognitive control by reducing subjective effort costs in Parkinson's patients. Neurobiology of Learning and Memory. 107652. PMID 35724812 DOI: 10.1016/j.nlm.2022.107652 |
0.093 |
|
| 2013 |
Arkadir D, Greene PE, Waters CH, Moskowitz CB, Sharp ME. Applause sign in clinically overlapping diseases: a case of TDP-43 proteinopathy. Parkinsonism & Related Disorders. 19: 774-5. PMID 23680421 DOI: 10.1016/j.parkreldis.2013.04.016 |
0.076 |
|
| 2022 |
Tissot C, Servaes S, Lussier FZ, Ferrari-Souza JP, Therriault J, Ferreira PCL, Bezgin G, Bellaver B, Teixeira Leffa D, Mathotaarachchi SS, Chamoun M, Stevenson J, Rahmouni N, Kang MS, Pallen V, ... ... Sharp M, et al. The association of age-related and off-target retention with longitudinal quantification of [F]MK6240 tau-PET in target regions. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 36396455 DOI: 10.2967/jnumed.122.264434 |
0.062 |
|
| 2017 |
Vilas D, Sharp M, Gelpi E, Genís D, Marder KS, Cortes E, Vonsattel JP, Tolosa E, Alcalay RN. Clinical and neuropathological features of progressive supranuclear palsy in Leucine rich repeat kinase (LRRK2) G2019S mutation carriers. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 29119599 DOI: 10.1002/Mds.27225 |
0.039 |
|
| 2012 |
Sharp ME, Chew JB, Heran MK, Pettersen JA. Delayed restricted diffusion in carbon monoxide leukoencephalopathy. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 39: 393-4. PMID 22547524 |
0.01 |
|
| Hide low-probability matches. |